Morbidity after induction therapy and surgery in non small cell lung cancer (NSCLC). Focus on pulmonary function [2]

Lung Cancer

Volumn 36, Issue 2, 2002, Pages 219-220

  Granone, P ^a   Cesario, A ^a   Margaritora, S ^a   Galetta, D ^a   Valente, S ^a   Corbo, G M ^a   Fumagalli, G ^a   Trodella, L ^a   D'Angelillo, R M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; LUNG VOLUME; MORBIDITY; MULTIPLE REGRESSION; PRIORITY JOURNAL; RADIOTHERAPY; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MORBIDITY; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RESPIRATORY FUNCTION TESTS;

EID: 0036221843     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00473-1     Document Type: Letter

References (5)

1. Post-operative complications in relation with induction therapy for lung cancer
2. Morbidity after surgery for non small cell lung carcinoma is not related to neoadjuvant chemotherapy
3. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy
4. Results of induction chemotherapy followed by surgical resection in patients with stage IIIa (N2) non small cell lung cancer: the importance of the nodal down-staging after chemotherapy
5. Concurrent radiochemotherapy for N2 NSCLC. Interim analysis